- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- IgAN
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefR
- Radiology Toolkit
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request a Presentation
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
Major Depressive Disorder In Chronic Kidney Disease
About This Event
Major Depressive Disorder In Chronic Kidney Disease
This is a PsychU & NephU Joint Live Event for NephU members in the Pittsburgh, PA area. In this presentation, the objectives are to:
- Overview of Major Depressive Disorder (MDD) and Chronic Didney Disease (CKD)/End Stage Renal Disease (ESRD).
- Discuss the high prevalence of depression in patients with CKD.
- Discuss how overlap of symptomatology between MDD and CKD makes diagnosing depression in the setting of CKD challenging.
- Discuss the association of MDD with poor outcomes in CKD.
- Discuss potential risk factors and mechanism of MDD in CKD.
- Discuss the cycle between MDD and ESRD.
- Address challenges in MDD management considerations in CKD patients.
Location
Eleven
1150 Smallman Street
Pittsburgh, Pennsylvania 15222 United States + Google Map412-201-5656 View Venue WebsiteFeatured Speakers
Jessica Kanai, PharmD
Nephrology Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Jessica Kanai PharmD, is a Nephrology Medical Science Liaison at Otsuka. Dr Kanai obtained her PharmD from Duquesne University in Pittsburgh, Pennsylvania. She completed her PGY-1 residency at Memorial Health University Medical Center in Savannah, Georgia where she stayed on and worked in both emergency medicine and internal medicine. She was responsible for a diverse patient population including those with end stage renal disease. Dr Kanai then went on to obtain her Australian pharmacy license and worked with numerous specialty services at the Royal Hobart Hospital such as neurosurgery, cardiology and pulmonology. Upon returning to the states, she became the nephrology pharmacist at WVU Medicine and was also involved in initiating pharmacy rounding services with WVU Medicine’s cardiology specialty. Dr Kanai is currently a licensed pharmacist in Pennsylvania and West Virginia.
Katie Sulkowski, PharmD
Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
*Drs Jessica Kanai and Katie Sulkowski are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
Registration
Related Events
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.